Open Nav

Please submit your session questions in advance at http://bit.ly/BIOCEO19question

Interpace Diagnostics

  • Jack Stover, Interpace Diagnostics

Interpace Diagnostics develops molecular diagnostic tests. You can be assured that all of the molecular tests we offer are driven by rigorous, validated science.

We power the future of molecular diagnostics, delivering cutting-edge and much-needed mutational analysis that helps risk-stratify for thyroid, pancreatic, and other cancers to better inform treatment decisions. The unique molecular diagnostic tests we offer enable healthcare providers to avoid unnecessary surgeries and better assess the risk of cancer progression in their patients.

  • Date:Monday, February 11
  • Time:10:15 AM - 10:30 AM
  • Room:Hudson/Empire
  • Location:7th Floor
  • Session Type:Company Presentation
  • Please submit your session questions in advance at:http://bit.ly/BIOCEO19question
  • Submission ID:23319
  • Company Presentation - Presentation Type:Publicly Traded Company
  • Goal for Presentation:The goal for the presentation is to educate investors and companies on Interpace Diagnostics.
  • Company Website:www.interpacediagnostics.com
  • Company HQ City:Parsippany
  • Company HQ State:New Jersey
  • Company HQ Country:United States
  • Ticker:IDXG
  • Exchange:NASDAQ
  • Main Therapeutic Focus:Diagnostics
  • Lead Product in Development:BarreGEN
  • Development Phase of Primary Product:Phase II
Speakers
Jack Stover
Interpace Diagnostics
Back